Article
A compounding pharmacy at the center of a national outbreak of fungal meningitis has voluntarily recalled all of its products, including numerous drugs for treating skin conditions.
Defining Treatment Options for Managing Chronic Atopic Dermatitis: Part 3
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Conference Recap: 2024 Society of Dermatology Physician Associates Fall Dermatology Conference
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
New Algorithm Proposes Targeted Lipase Monitoring for Pancreatic Adverse Events In Melanoma
Heart Transplant Recipients are More Susceptible to Skin Cancer